日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial.

Linavonkibart 和 pembrolizumab 治疗免疫检查点阻断耐药的晚期实体瘤:一项 1 期试验。

Yap Timothy A, Sweis Randy F, Vaishampayan Ulka, Kilari Deepak, Gainor Justin F, McKean Meredith, Barve Minal, Tarhini Ahmad A, Bockorny Bruno, Sonpavde Guru, Park David, Babu Sunil, Ju Yawen, Liu Lan, Henry Susan, Tirucherai Giridhar S, DeWall Stephen, Qatanani Mohammed, Marantz Jing L, Gan Lu

Circulating Tumor Cells Predict Response to the DLL3-targeting Bispecific Antibody Tarlatamab.

循环肿瘤细胞可预测对靶向 DLL3 的双特异性抗体 Tarlatamab 的反应。

Mishra Avanish, Meador Catherine B, Kikkeri Kruthika, Cunneely Quinn, Lin Maoxuan, Carmona-LaSalle Thomas J, Huang Shih-Bo, Bell Remy, Putaturo Victor, Xia Weikun, Liang Joyce H, Fang Jacy, San Vicente Sarah, Zielinski Caroline E, Digumarthy Subba R, Hung Yin P, Yeap Beow Y, Edd Jon F, Lawrence Michael S, Sade-Feldman Moshe, Sen Debattama R, Toner Mehmet, Maheswaran Shyamala, Gainor Justin F, Haber Daniel A

Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium

RET 改变实体瘤中选择性 RET 抑制剂耐药的基因组机制图谱:RETregistry 全球联盟分析

Waliany, Sarah; Cooper, Alissa J; Liu, Stephen V; Gautschi, Oliver; Rotow, Julia K; Smith, Katherine Emilie Rhoades; Weber, Urs M; Lee, Dae Ho; Loong, Herbert H F; Patel, Jyoti D; Pennell, Nathan A; Nagasaka, Misako; Patel, Shetal A; Tan, Daniel S W; Solomon, Benjamin J; Kim, Tae Min; Pall, Georg; Riess, Jonathan W; Sun, Lova; Früh, Martin; Uy, Natalie F; Gadgeel, Shirish; Feng, Jamie; Do, Andrew; Falcon, Christina; Leighl, Natasha B; Baik, Christina S; Lai, Gillianne G Y; Ou, S Ignatius; Cheung, Kingsley S Y; Patil, Tejas; Mansfield, Aaron S; Weiler, Daniela; Yeap, Beow Y; Wirth, Lori J; Gainor, Justin F; Drilon, Alexander; Lin, Jessica J

Global advances and future directions in lung cancer care: expert consensus and strategic priorities

全球肺癌治疗进展及未来方向:专家共识和战略重点

Meyer, M-L; Peters, S; Jänne, P A; Mok, T S; Bunn, P A; Abdel Karim, N; Altorki, N K; Arrieta, O; Bar, J; Cappuzzo, F; Carbone, D; Dacic, S; Diehn, M; Dziadziuszko, R; Felip, E; Flores, R; Florez, N; Forde, P M; Gainor, J F; Gray, J E; Gros, L; Halmos, B; Henschke, C I; Herbst, R; Heymach, J V; Kelly, K; Kris, M G; Leighl, N B; Mathias, C; Marron, T U; Mulshine, J L; Naidoo, J; Osarogiagbon, R; Passaro, A; Peled, N; Planchard, D; Politi, K; Popat, S; Pyenson, B; Reckamp, K L; Ren, S H; Riely, G J; Rolfo, C; Rudin, C M; Sen, T; Shields, M D; Singh, H; Skoulidis, F; Solomon, B J; Stahel, R; Stiles, B M; Syrigos, K; Yang, J C-H; Yang, P-C; Wolf, A; Wozniak, A J; Waqar, S N; Wakelee, H; Hirsch, F R

Fast Real-Time Assessment of Combination Therapies in Immuno-ONcology in patients with advanced non-small-cell lung cancer (FRACTION-Lung)

快速实时评估免疫肿瘤学联合疗法在晚期非小细胞肺癌患者中的应用(FRACTION-Lung)

He, K; Forde, P M; Govindan, R; Santoro, A; Gettinger, S; Borghaei, H; Spira, A; Chu, Q; Zinner, R; Schoenfeld, A J; Camidge, D R; Spigel, D R; Gurpide, A; Juergens, R A; Laurie, S A; Cerra, M; Spires, T; Greenawalt, D M; Rapoport, I; Gainor, J F

Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study

在II期至III期非小细胞肺癌患者计划接受新辅助化疗免疫治疗后,进行根治性放疗(联合或不联合化疗):一项国际多中心回顾性研究

Adib, Elio; Nassar, Amin H; Lee, Katie N; Fusco, Francesca; Crowley, Fionnuala; Baena, Javier; Worth, John Emmett; Abi Jaoude, Joseph; Addeo, Alfredo; Bou Farhat, Elias; Rakaee, Mehrdad; Amini, Arya; Lambden, Jason; Rost, Maximilian; Bolnykh, Iakov; Aboubakar Nana, Frank; Aujayeb, Avinash; Cortellini, Alessio; Newsom-Davis, Thomas; Camidge, D Ross; Vitzthum, Lucas K; Cappuzzo, Federico; Marron, Thomas U; Lanuti, Michael; Gainor, Justin F; Kwiatkowski, David J; Park, Henry S; Owen, Dawn; Keane, Florence K

Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS(G12C) inhibitors

KRAS(G12C)抑制剂治疗患者临床获得性耐药性改变的基因组图谱

Riedl, J M; Fece de la Cruz, F; Lin, J J; Parseghian, C; Kim, J E; Matsubara, H; Barnes, H; Caughey, B; Norden, B L; Morales-Giron, A A; Kushner, E W; Ehnstrom, S; Nakamura, H; Patel, P S; Ellis, H; Pappas, L; Vakaris, A; Gainor, J F; Kopetz, S; Klempner, S J; Parikh, A R; Hata, A N; Heist, R S; Corcoran, R B

Oxidation of retromer complex controls mitochondrial translation

逆转录酶复合物的氧化控制线粒体翻译

Zhang, Junbing; Ali, Md Yousuf; Chong, Harrison Byron; Tien, Pei-Chieh; Woods, James; Noble, Carolina; Vornbäumen, Tristan; Ordulu, Zehra; Possemato, Anthony P; Harry, Stefan; Fonticella, Jay Miguel; Fellah, Lina; Harrison, Drew; Ge, Maolin; Khandelwal, Neha; Huang, Yingfei; Chauvin, Maëva; Bischof, Anica Tamara; Hambelton, Grace Marie; Gohar, Magdy Farag; Zhang, Siwen; Choi, MinGyu; Bouberhan, Sara; Oliva, Esther; Mino-Kenudson, Mari; Pavlova, Natalya N; Lawrence, Michael; Gainor, Justin F; Beausoleil, Sean A; Bardeesy, Nabeel; Mostoslavsky, Raul; Pépin, David; Ott, Christopher J; Liau, Brian; Bar-Peled, Liron

Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer

缺氧与肺癌对免疫检查点抑制剂的获得性耐药有关

Camila Robles-Oteíza,Katherine Hastings,Jungmin Choi,Isabelle Sirois,Arvind Ravi,Francisco Expósito,Fernando de Miguel,James R Knight,Francesc López-Giráldez,Hyejin Choi,Nicholas D Socci,Taha Merghoub ,Mark Awad,Gad Getz ,Justin Gainor,Matthew D Hellmann,Étienne Caron,Susan M Kaech,Katerina Politi

Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer

缺氧与肺癌对免疫检查点抑制剂的获得性耐药有关

Camila Robles-Oteíza ,Katherine Hastings ,Jungmin Choi ,Isabelle Sirois ,Arvind Ravi ,Francisco Expósito ,Fernando de Miguel ,James R Knight ,Francesc López-Giráldez ,Hyejin Choi ,Nicholas D Socci ,Taha Merghoub ,Mark Awad ,Gad Getz ,Justin Gainor ,Matthew D Hellmann ,Étienne Caron ,Susan M Kaech ,Katerina Politi